CDK4 phosphorylation status and rational use for combining CDK4/6 and BRAF/MEK inhibition in advanced thyroid carcinomasJaime Miguel Gomes Pita, Pierre P. Roger|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 1